• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ATP13A2及相关P型转运ATP酶在帕金森病和其他神经疾病中的细胞功能及病理作用

Cellular function and pathological role of ATP13A2 and related P-type transport ATPases in Parkinson's disease and other neurological disorders.

作者信息

van Veen Sarah, Sørensen Danny M, Holemans Tine, Holen Henrik W, Palmgren Michael G, Vangheluwe Peter

机构信息

Laboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, KU Leuven Leuven, Belgium.

Department of Plant and Environmental Sciences, Centre for Membrane Pumps in Cells and Disease - PUMPkin, University of Copenhagen Frederiksberg, Denmark.

出版信息

Front Mol Neurosci. 2014 May 27;7:48. doi: 10.3389/fnmol.2014.00048. eCollection 2014.

DOI:10.3389/fnmol.2014.00048
PMID:24904274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4033846/
Abstract

Mutations in ATP13A2 lead to Kufor-Rakeb syndrome, a parkinsonism with dementia. ATP13A2 belongs to the P-type transport ATPases, a large family of primary active transporters that exert vital cellular functions. However, the cellular function and transported substrate of ATP13A2 remain unknown. To discuss the role of ATP13A2 in neurodegeneration, we first provide a short description of the architecture and transport mechanism of P-type transport ATPases. Then, we briefly highlight key P-type ATPases involved in neuronal disorders such as the copper transporters ATP7A (Menkes disease), ATP7B (Wilson disease), the Na(+)/K(+)-ATPases ATP1A2 (familial hemiplegic migraine) and ATP1A3 (rapid-onset dystonia parkinsonism). Finally, we review the recent literature of ATP13A2 and discuss ATP13A2's putative cellular function in the light of what is known concerning the functions of other, better-studied P-type ATPases. We critically review the available data concerning the role of ATP13A2 in heavy metal transport and propose a possible alternative hypothesis that ATP13A2 might be a flippase. As a flippase, ATP13A2 may transport an organic molecule, such as a lipid or a peptide, from one membrane leaflet to the other. A flippase might control local lipid dynamics during vesicle formation and membrane fusion events.

摘要

ATP13A2基因的突变会导致库福-拉凯布综合征,这是一种伴有痴呆的帕金森症。ATP13A2属于P型转运ATP酶,这是一类发挥重要细胞功能的初级主动转运蛋白大家族。然而,ATP13A2的细胞功能和转运底物仍不清楚。为了探讨ATP13A2在神经退行性变中的作用,我们首先简要描述一下P型转运ATP酶的结构和转运机制。然后,我们简要强调参与神经元疾病的关键P型ATP酶,如铜转运蛋白ATP7A(门克斯病)、ATP7B(威尔逊病)、钠/钾-ATP酶ATP1A2(家族性偏瘫性偏头痛)和ATP1A3(快速发作性肌张力障碍帕金森症)。最后,我们回顾了关于ATP13A2的最新文献,并根据其他研究较深入的P型ATP酶的已知功能,讨论ATP13A2可能的细胞功能。我们批判性地回顾了有关ATP13A2在重金属转运中作用的现有数据,并提出了一个可能的替代假说,即ATP13A2可能是一种翻转酶。作为一种翻转酶,ATP13A2可能将一种有机分子,如脂质或肽,从一个膜小叶转运到另一个膜小叶。翻转酶可能在囊泡形成和膜融合事件中控制局部脂质动力学。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d16d/4033846/2f61dde5e58d/fnmol-07-00048-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d16d/4033846/8fe09b0d6d97/fnmol-07-00048-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d16d/4033846/3e0489e982a8/fnmol-07-00048-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d16d/4033846/deb9c009dd27/fnmol-07-00048-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d16d/4033846/ee9c890181d0/fnmol-07-00048-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d16d/4033846/2f61dde5e58d/fnmol-07-00048-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d16d/4033846/8fe09b0d6d97/fnmol-07-00048-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d16d/4033846/3e0489e982a8/fnmol-07-00048-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d16d/4033846/deb9c009dd27/fnmol-07-00048-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d16d/4033846/ee9c890181d0/fnmol-07-00048-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d16d/4033846/2f61dde5e58d/fnmol-07-00048-g0005.jpg

相似文献

1
Cellular function and pathological role of ATP13A2 and related P-type transport ATPases in Parkinson's disease and other neurological disorders.ATP13A2及相关P型转运ATP酶在帕金森病和其他神经疾病中的细胞功能及病理作用
Front Mol Neurosci. 2014 May 27;7:48. doi: 10.3389/fnmol.2014.00048. eCollection 2014.
2
Hereditary Parkinsonism-Associated Genetic Variations in PARK9 Locus Lead to Functional Impairment of ATPase Type 13A2.帕金森病相关基因PARK9位点的遗传变异导致13A2型ATP酶功能受损。
Curr Protein Pept Sci. 2017;18(7):725-732. doi: 10.2174/1389203717666160311121534.
3
α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9).在帕金森病大鼠模型中,α-突触核蛋白诱导的多巴胺能神经退行性变独立于ATP13A2(PARK9)发生。
Neurobiol Dis. 2015 Jan;73:229-43. doi: 10.1016/j.nbd.2014.10.007. Epub 2014 Oct 18.
4
A lipid switch unlocks Parkinson's disease-associated ATP13A2.一种脂质开关激活与帕金森病相关的ATP13A2。
Proc Natl Acad Sci U S A. 2015 Jul 21;112(29):9040-5. doi: 10.1073/pnas.1508220112. Epub 2015 Jul 1.
5
Structural mechanisms for gating and ion selectivity of the human polyamine transporter ATP13A2.人多胺转运体 ATP13A2 的门控和离子选择性的结构机制。
Mol Cell. 2021 Nov 18;81(22):4650-4662.e4. doi: 10.1016/j.molcel.2021.10.002. Epub 2021 Oct 28.
6
Deficiency of ATP13A2 leads to lysosomal dysfunction, α-synuclein accumulation, and neurotoxicity.ATP13A2 缺乏导致溶酶体功能障碍、α-突触核蛋白堆积和神经毒性。
J Neurosci. 2012 Mar 21;32(12):4240-6. doi: 10.1523/JNEUROSCI.5575-11.2012.
7
Identification of novel ATP13A2 interactors and their role in α-synuclein misfolding and toxicity.鉴定新型 ATP13A2 相互作用蛋白及其在α-突触核蛋白错误折叠和毒性中的作用。
Hum Mol Genet. 2012 Sep 1;21(17):3785-94. doi: 10.1093/hmg/dds206. Epub 2012 May 29.
8
Lysosomal defects in ATP13A2 and GBA associated familial Parkinson's disease.ATP13A2 和 GBA 相关家族性帕金森病中的溶酶体缺陷。
J Neural Transm (Vienna). 2017 Nov;124(11):1395-1400. doi: 10.1007/s00702-017-1779-7. Epub 2017 Sep 11.
9
ATP13A2 (PARK9) and basal ganglia function.ATP13A2(PARK9)与基底神经节功能。
Front Neurol. 2024 Jan 5;14:1252400. doi: 10.3389/fneur.2023.1252400. eCollection 2023.
10
Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes.与帕金森病相关的人类PARK9/ATP13A2维持锌稳态并通过外泌体促进α-突触核蛋白外化。
Hum Mol Genet. 2014 Jun 1;23(11):2816-33. doi: 10.1093/hmg/ddu099. Epub 2014 Mar 6.

引用本文的文献

1
Case Report: Novel pathogenic variants associated with early-onset parkinsonism and a mini-review.病例报告:与早发性帕金森病相关的新型致病变异及文献综述
Front Genet. 2025 Jul 29;16:1588812. doi: 10.3389/fgene.2025.1588812. eCollection 2025.
2
Subtle concentration changes in zinc hold the key to fibrillation of α-synuclein: an updated insight on the micronutrient's role in prevention of neurodegenerative disorders.锌的细微浓度变化是α-突触核蛋白纤维化的关键:对这种微量营养素在预防神经退行性疾病中作用的最新见解。
Front Mol Biosci. 2025 Jul 10;12:1603364. doi: 10.3389/fmolb.2025.1603364. eCollection 2025.
3
Neuronal Ceroid Lipofuscinosis-Concepts, Classification, and Avenues for Therapy.

本文引用的文献

1
Critical roles of isoleucine-364 and adjacent residues in a hydrophobic gate control of phospholipid transport by the mammalian P4-ATPase ATP8A2.Ile364 和相邻残基在哺乳动物 P4-ATPase ATP8A2 控制磷脂转运的疏水性门控中的关键作用。
Proc Natl Acad Sci U S A. 2014 Apr 8;111(14):E1334-43. doi: 10.1073/pnas.1321165111. Epub 2014 Mar 24.
2
Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes.与帕金森病相关的人类PARK9/ATP13A2维持锌稳态并通过外泌体促进α-突触核蛋白外化。
Hum Mol Genet. 2014 Jun 1;23(11):2816-33. doi: 10.1093/hmg/ddu099. Epub 2014 Mar 6.
3
神经元蜡样脂褐质沉积症——概念、分类及治疗途径
CNS Neurosci Ther. 2025 Feb;31(2):e70261. doi: 10.1111/cns.70261.
4
Different charged biopolymers induce α-synuclein to form fibrils with distinct structures.不同电荷的生物聚合物诱导α-突触核蛋白形成具有不同结构的纤维。
J Biol Chem. 2024 Nov;300(11):107862. doi: 10.1016/j.jbc.2024.107862. Epub 2024 Oct 5.
5
Mechanisms of autophagy-lysosome dysfunction in neurodegenerative diseases.神经退行性疾病中自噬-溶酶体功能障碍的机制。
Nat Rev Mol Cell Biol. 2024 Nov;25(11):926-946. doi: 10.1038/s41580-024-00757-5. Epub 2024 Aug 6.
6
Nigral ATP13A2 depletion induces Parkinson's disease-related neurodegeneration in a pilot study in non-human primates.在一项针对非人类灵长类动物的初步研究中,黑质ATP13A2缺失会引发帕金森病相关的神经退行性变。
NPJ Parkinsons Dis. 2024 Aug 1;10(1):141. doi: 10.1038/s41531-024-00757-4.
7
A noncanonical polyamine from bacteria antagonizes animal mitochondrial function.一种来自细菌的非经典多胺可拮抗动物线粒体功能。
bioRxiv. 2025 Jan 23:2024.04.29.591726. doi: 10.1101/2024.04.29.591726.
8
Genetic Evidence for Endolysosomal Dysfunction in Parkinson's Disease: A Critical Overview.遗传证据表明帕金森病中内溶酶体功能障碍:批判性综述。
Int J Mol Sci. 2023 Mar 28;24(7):6338. doi: 10.3390/ijms24076338.
9
Role of Astrocytes in Parkinson's Disease Associated with Genetic Mutations and Neurotoxicants.星形胶质细胞在与基因突变和神经毒素相关的帕金森病中的作用。
Cells. 2023 Feb 15;12(4):622. doi: 10.3390/cells12040622.
10
Paraganglioma with High Levels of Dopamine, Dopa Decarboxylase Suppression, Dopamine β-hydroxylase Upregulation and Intra-tumoral Melanin Accumulation: A Case Report with a Literature Review.多巴胺水平升高、多巴脱羧酶抑制、多巴胺 β-羟化酶上调及肿瘤内黑色素堆积的副神经节瘤:病例报告并文献复习。
Intern Med. 2023 Jul 1;62(13):1895-1905. doi: 10.2169/internalmedicine.0743-22. Epub 2022 Nov 16.
ATP1A3 mutations: what is the phenotype?
ATP1A3突变:其表型是什么?
Neurology. 2014 Feb 11;82(6):468-9. doi: 10.1212/WNL.0000000000000113. Epub 2014 Jan 15.
4
Parkinson's disease-associated human ATP13A2 (PARK9) deficiency causes zinc dyshomeostasis and mitochondrial dysfunction.帕金森病相关的人类ATP13A2(PARK9)缺乏会导致锌稳态失衡和线粒体功能障碍。
Hum Mol Genet. 2014 Jun 1;23(11):2802-15. doi: 10.1093/hmg/ddt623. Epub 2014 Jan 7.
5
Zn²⁺ dyshomeostasis caused by loss of ATP13A2/PARK9 leads to lysosomal dysfunction and alpha-synuclein accumulation.由ATP13A2/PARK9缺失导致的锌离子稳态失衡会引发溶酶体功能障碍和α-突触核蛋白聚集。
Hum Mol Genet. 2014 Jun 1;23(11):2791-801. doi: 10.1093/hmg/ddt572. Epub 2013 Dec 13.
6
The Sybtraps: control of synaptobrevin traffic by synaptophysin, α-synuclein and AP-180.Sybtraps:突触小泡蛋白、α-突触核蛋白和 AP-180 对突触融合蛋白运输的调控。
Traffic. 2014 Mar;15(3):245-54. doi: 10.1111/tra.12140. Epub 2013 Dec 16.
7
Genetics in dystonia.扭转痉挛的遗传学。
Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S137-42. doi: 10.1016/S1353-8020(13)70033-6.
8
Manganese and the brain.锰与大脑。
Int Rev Neurobiol. 2013;110:277-312. doi: 10.1016/B978-0-12-410502-7.00013-2.
9
CATP-6, a C. elegans ortholog of ATP13A2 PARK9, positively regulates GEM-1, an SLC16A transporter.CATP-6是ATP13A2 PARK9的秀丽隐杆线虫直系同源物,正向调控SLC16A转运蛋白GEM-1。
PLoS One. 2013 Oct 9;8(10):e77202. doi: 10.1371/journal.pone.0077202. eCollection 2013.
10
Mitochondrial dysfunctions in Parkinson's disease.帕金森病中的线粒体功能障碍。
Rev Neurol (Paris). 2014 May;170(5):339-43. doi: 10.1016/j.neurol.2013.06.003. Epub 2013 Oct 9.